JG
DGX icon

Jefferies Group’s Quest Diagnostics DGX Stock Holding History

Jefferies Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$1.28M – 1739
2021
Q1 		$1.28M Buy
+10,000
New +$1.23M 0.01% 825
2018
Q4 		– Sell
-50,000
Closed -$5.4M – 2224
2018
Q3 		$5.4M Buy
+50,000
New +$5.48M 0.04% 509

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's DGX Position: Q3 2022 in Review

Jefferies Group opened a new position in Quest Diagnostics (DGX) in Q3 2022: 34,200 shares worth $4.2M. The stake represents 0.04% of the portfolio and ranks #382 among its holdings. This is a return to the name: Jefferies Group previously reported a position in DGX as recently as Q4 2021.

Jefferies Group first reported a position in DGX in Q2 2013 and has held it in 27 quarters since. The position peaked at $19.7M in Q2 2021. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Jefferies Group held 34,200 shares of Quest Diagnostics worth $4.2M as of Q3 2022.
  • Quest Diagnostics was a new Jefferies Group position in Q3 2022.
  • Quest Diagnostics made up 0.04% of Jefferies Group's portfolio in Q3 2022, its #382 holding.
  • Jefferies Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 27 quarters since.
  • Jefferies Group's Quest Diagnostics position peaked at $19.7M in Q2 2021.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.